青少年接种辉瑞/BioNTech新冠疫苗后心肌炎的心脏磁共振晚期钆增强短期转归
本研究纳入5名接种辉瑞/BioNTech新冠疫苗后发生急性心肌炎的青少年,共进行8次心脏磁共振检查。急性期部分患者存在心肌水肿,随访时水肿消退但所有初始有水肿者均遗留晚期钆增强,提示心肌炎后纤维化。
要点
- 疫苗接种后心肌炎急性期可表现为STIR T2WI心肌水肿。
- 水肿消退后随访仍可见晚期钆增强,提示纤维化残留。
- 需重视疫苗接种后心肌炎的影像随访与转归评估。
关键影像表现/征象
- 3名青少年在症状出现后3-12天首次MRI的STIR T2WI上显示心肌水肿。
- 上述3名患者在首次MRI后53-68天随访时心肌水肿/急性炎症已消退。
- 上述3名患者随访时均可见持续存在的晚期钆增强区域,提示心肌炎后纤维化。
- 1名仅在一次扫描(症状后66天)中显示无急性炎症但持续纤维化改变。
- 另1名在症状后109天首次扫描,表现符合既往心肌炎发作,伴轻度持续区域性心肌水肿/炎症。
临床应用与阅片要点
- 对疫苗接种后心肌炎患者,急性期应关注STIR T2WI上的心肌水肿。
- 随访MRI应评估晚期钆增强,即使水肿已消退也需警惕纤维化残留。
- 报告时应描述水肿与晚期钆增强的范围及转归变化。
局限性
- 样本量小(5名青少年),仅来自两个机构。
- 部分患者扫描次数有限,随访时间不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Rare cases of cardiac inflammation following vaccination for severe acute respiratory coronavirus 2 (SARS-CoV-2) have been reported.
OBJECTIVE: To study paediatric patients with clinical findings of acute inflammation post coronavirus disease 2019 (COVID-19) Pfizer/BioNTech vaccination using cardiovascular magnetic resonance imaging (MRI) in acute and subacute phases.
MATERIALS AND METHODS: We enrolled adolescents younger than 18 years who presented at one of two institutions between July 2021 and August 2022 with clinical and laboratory findings of acute myocarditis shortly following COVID-19 Pfizer/BioNTech vaccination. They all underwent cardiovascular MRI using the institutional myocarditis protocol.
RESULTS: Five adolescents (four boys) underwent eight scans between 3 days and 109 days (mean 49 days) after the onset of symptoms following COVID-19 vaccination. Myocardial oedema appeared on short tau inversion recovery (STIR) T2-weighted images in three adolescents at presentation (3-12 days after symptom onset). In these children, the myocardial oedema/acute inflammation had resolved at follow-up cardiovascular MRI (53-68 days after first MRI). However, in all three adolescents, a persistent area of late gadolinium enhancement was evident at follow-up, suggesting post-myocarditic fibrosis. One adolescent scanned only once, 66 days after being symptomatic, had no acute inflammation but persistent fibrotic changes. This last adolescent, who underwent the first scan 109 days after symptom onset, had findings compatible with an episode of previous myocarditis, with mild ongoing regional myocardial oedema/inflammation.
CONCLUSION: This study on post-vaccine myocarditis demonstrates residual lesions with persistent areas of late gadolinium enhancement/myocardial fibrosis with ongoing myocardial oedema after resolution of the initial myocardial oedema a few weeks after Pfizer/BioNTech vaccination. There is an urgent need to recognise and fully investigate the outcome of post-vaccination myocarditis.
引用
- Krupickova, Voges, Mohiaddin, et al. Short-term outcome of late gadolinium changes detected on cardiovascular magnetic resonance imaging following coronavirus disease 2019 Pfizer/BioNTech vaccine-related myocarditis in adolescents. Pediatr Radiol. 2023. PMID: 36622403. doi:10.1007/s00247-022-05573-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。